Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://orlandohoqw797842.like-blogs.com/38797484/retaglutide-a-promising-glp-1-receptor-agonist